351523-08-5

Basic information

• Product Name: 1-(3,5-O-di(tetrahydropyran-2-yl)-β-D-arabinofuranosyl)thymine
• Synonyms: 1-(3,5-O-di(tetrahydropyran-2-yl)-β-D-arabinofuranosyl)thymine
• CAS NO: 351523-08-5
• Molecular Weight: 426.467
• Mol File: 351523-08-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-(3,5-O-di(tetrahydropyran-2-yl)-β-D-arabinofuranosyl)thymine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3,5-O-di(tetrahydropyran-2-yl)-β-D-arabinofuranosyl)thymine(351523-08-5)
• EPA Substance Registry System: 1-(3,5-O-di(tetrahydropyran-2-yl)-β-D-arabinofuranosyl)thymine(351523-08-5)

Safety Data

• Hazardous Substances Data: 351523-08-5(Hazardous Substances Data)

Upstream product

• 22423-26-3 O-2,2'-cyclo-5-methyluridine 

Downstream Products

• 1054489-94-9 tert-butyl 5-methyl-2,6-dioxo-3-((2R,3S,4R,5R)-4-(tetrahydro-2H-pyran-2-yloxy)-5-((tetrahydro-2H-pyran-2-yloxy)methyl)-3-(2-(tosyloxy)ethoxy)tetrahydrofuran-2-yl)-2,3-dihydropyrimidine-1(6H)-carboxylate 
• 1054490-24-2 2-(3-((2R,3S,4R,5R)-3-(tert-butoxycarbonyloxy)-4-(tetrahydro-2H-pyran-2-yloxy)-5-((tetrahydro-2H-pyran-2-yloxy)methyl)tetrahydrofuran-2-yl)-5-methyl-2,6-dioxo-2,3-dihydropyrimidin-1(6H)-yl)ethyl 4-methylbenzenesulfonate 
• 122799-38-6 1-(2'-deoxy-2'-fluoro-β-D-ribofuranosyl)-5-methyluracil 
• 351523-11-0 1-[(2R,3S,4R,5R)-3-Benzyloxy-4-(tetrahydro-pyran-2-yloxy)-5-(tetrahydro-pyran-2-yloxymethyl)-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 

Relevant articles and documents

NUCLEOSIDE BASED PROLIFERATION IMAGING MARKERS

Disclosed herein are novel radiolabeled nucleosides and methods for detecting cellular proliferation in a mammal, the method comprising administrating an effective amount of a radiolabeled nucleoside; the method comprising: a) administering to the mammal a diagnostically effective amount of the nucleoside to the mammal; b) allowing the nucleoside to distribute into the effective tissue; and c) imaging the tissue, wherein an increase in binding of the compound to tissue compared to a normal control level of binding indicates that the mammal is suffering from a disease involving cellular proliferation.